Real-time enrollment status for this b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: October 18, 2026 at 12:05 AM UTC
| NCT Number | NCT05006716 |
| Recruiting Status | Recruiting |
| Condition | B-Cell Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 689 participants |
| Active Locations | 31 sites in the US |
| Sponsor | BeiGene |
| Last Updated on CT.gov | October 5, 2026 (1 week ago) |
As of October 18, 2026: Clinical trial NCT05006716 is currently recruiting participants. This phase1 study for b-cell lymphoma is actively seeking new participants at 31 locations across the United States. The study is sponsored by BeiGene. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05006716 is actively recruiting participants as of October 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 31 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05006716 was last updated 1 week ago (October 5, 2026). HelloStudys verifies this status automatically.